Stock Quote

VaxGen, Inc. (VXGN.OB) (OTC BB)
As of  27 Nov 2009
0.65USD
Price Change
+0.04
Percent Change
+6.56%
 
$0.65
27 Nov 2009
+6.56%
$0.61
$0.65
1,000
$0.65
$0.55
$1.00
$0.33
1.02
133,403

Research Another Stock: Symbol Look-up
The Value of Unconventional Investment Research
Monday, 19 Oct 2009 07:48am EDT(Seeking Alpha) 
VaxGen: Still a Good Prospect
Tuesday, 4 Aug 2009 07:20am EDT(Seeking Alpha) 
VaxGen Still Looking to Return Value to Its Stockholders
Thursday, 26 Mar 2009 08:22am EDT(SeekingAlpha) 
SAC Capital Portfolio Update: 37 13G Filings
Thursday, 15 Jan 2009 06:25am EST(SeekingAlpha) 
 
Name Current Position Compensation
Reilly, Kevin Chairman of the Board --
Panek, James President, Principal Financial Officer, Director 667,382
Berger, Franklin Director --

Profile

VaxGen, Inc., (VaxGen) is a biopharmaceutical company. VaxGen is focused on the development, manufacture and commercialization of biologic products for the treatment of human disease. The Company owns a state-of-the-art biopharmaceutical manufacturing facility with a 1,000-liter bioreactor that can... Full Description

Company Address

VaxGen, Inc.
349 Oyster Point Boulevard
South San Francisco   CA   94080
P: +1650.6241000
F: +1650.6241001

Analyst Research

  VXGN.OB Industry
P/E(TTM) -- 3.68
P/S(TTM) -- 0.56
ROI(TTM) -12.62 1.88
ROE(TTM) -15.87 2.54
No consensus estimates data available.
Total Revenue $0.00M
Net Income $-1.90M
EPS $-0.06